SBILIFE's Q2 FY27 numbers came in mixed, with revenue of Rs. 26,877.70 Cr (+8.17% YoY) and PAT growth of +11.05% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 27, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 26,877.70 Cr (+8.17% YoY) |
| PAT (Q2) | Rs. 549.23 Cr (+11.05% YoY) |
| EPS (Q2) | Rs. 5.47 (+10.95% YoY) |
| Market cap | Rs. 164,026.38 Cr |
| CMP | Rs. 1,633.00 |
SBI Life delivered 8.17% NPM growth with PAT up 11.05% YoY and H1 VoNB up 18.91% YoY, tracking at or above the pace needed for its 14% APE growth target. Persistency improved across cohorts and solvency strengthened to 1.97, but premium growth decelerated from Q1, investment yields compressed with negative mark-to-market yields, and the non-par individual life deficit widened to −Rs.1,098.01 cr. No guidance beat can be assessed as VNB margin and APE levels were not disclosed in the filing.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.